News Archive

2017

Reagan-Udall Foundation Annual Public Meeting

May 4, 2017: The Reagan-Udall Foundation for the Food and Drug Administration (FDA) will hold its annual public meeting on May 4th, 10am-11:45am at the offices of Alston & Bird LLP, 950 F Street, NW, Washington, DC. Acting FDA Commissioner Stephen Ostroff will provide opening remarks. Read the full press release here.

2016

Reagan-Udall Foundation Announces Appointment of New Board Chairman & Vice Chairman

November 21, 2016: The Reagan-Udall Foundation for the FDA (RUF) has elected Ellen V. Sigal, PhD, as its new Chairman and Richard L. Schilsky, MD, as Vice Chair of the RUF Board of Directors. Read the full article here.

Reagan-Udall Foundation Hosts First BD4P Training Workshop

October 24, 2016: The Reagan-Udall Foundation for the FDA (RUF) hosted the first Big Data for Patients (BD4P) Training Workshop on October 13-15 at Gallaudet University in Washington, DC. Read the full article here.

Reagan-Udall Foundation Announces Opening of Applications for BD4P Training

August 3, 2016: The Reagan-Udall Foundation for the FDA (RUF) is excited to announce the opening of the application period for the Big Data for Patients(BD4P) Training Workshop. The training will facilitate meaningful participation in biomedical big data research efforts by equipping trainees with the knowledge, skills, and tools needed to both navigate and impact this work. Read the full announcement here.

Reagan-Udall Foundation Announces New Executive Director

May 16, 2016: The Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA) is pleased to announce the appointment of June Wasser, M.A., as its executive director. Read the full announcement here.

Reagan-Udall Foundation Announces Collaboration with UMD on BD4P Project

April 29, 2016: The Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA) and University of Maryland are pleased to announce a new collaboration for the Big Data for Patients (BD4P) program. Read full announcement here.

 

2015

Reagan-Udall Foundation Announces the Steering Committee for Big Data for Patients (BD4P) Program

October 19, 2015: The Reagan-Udall Foundation announces appointments to the Big Data for Patients (BD4P) Program Steering Committee. [details]

Reagan-Udall Foundation Announces Leadership Transition

October 5, 2015: The Reagan-Udall Foundation announces the resignation of Executive Director, Jane Reese-Coulbourne. [details]

Reagan-Udall Foundation Hosting Big Data for Patients (BD4P) Webinar

September 14, 2015: The Reagan-Udall Foundation is hosting a BD4P informative webinar. [details]

Reagan-Udall Foundation Seeks Nominations for its Big Data for Patients (BD4P) Program Steering Committee

August 6, 2015: The Reagan-Udall Foundation announces Big Data for Patients (BD4P) Program Steering Committee and nomination process. [details]

Reagan-Udall Foundation Seeks Nominations for PredicTox Steering Committee

July 24, 2015: The Reagan-Udall Foundation announces PredicTox Program Steering Committee nomination and selection process. [details]

Reagan-Udall Foundation for the FDA Announces Big Data Training Program for Patients and Advocates

July 9, 2015: The Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA) today announced a new program, Big Data for Patients (BD4P), that will provide specialized training for patients and advocates on the emerging field of data science. BD4P will equip patient advocates with the knowledge and tools they need to impact Big Data issues through communication with policy makers, scientists, physicians and other patients.. For more details, please see the full press release, here.

 

2014

Funding Extended For Reagan-Udall Foundation for the FDA Tuberculosis Drug Regimen Development Project

December 16, 2014: The Reagan-Udall Foundation for the FDA announces new grant funding to support their work in the Critical Path to TB Drug Regimens (CPTR) initiative. Work will be focused on facilitating community engagement in TB drug development and addressing critical regulatory scientific challenges that currently impede TB research and development. For more details, please see the full press release, here.

Reagan-Udall Foundation Announces New Board Chairman

July 14, 2014: The Reagan-Udall Foundation for the FDA (RUF), an independent not-for-profit organization created by Congress for the purpose of advancing regulatory science critical to helping the U.S. Food and Drug Administration accomplish its mission, today announced that Mark C. Rogers, M.D., M.B.A., has been elected as Chairman of the RUF Board of Directors. For details, see full announcement here.

IMEDS Program Announces Request for Proposal (RFP)

April 4, 2014: The Reagan-Udall Foundation for the FDA has released a Request for Proposal to solicit proposals to participate in the evaluation of protocol-based findings using IMEDS data. The solicitation, “Recreate Mini-Sentinel Protocol-Based Findings,” is an evaluation to assess whether or not there are any differences in results between the Mini-Sentinel system and the IMEDS system. Link here for the complete IMEDS Methods Research Agenda and RFP. The RFP submission deadline is June 2, 2014.

Reagan-Udall Foundation Announces Annual Public Meeting

April 4, 2014: The Reagan-Udall Foundation for the Food and Drug Administration (FDA), is announcing it’s annual open public meeting. The Foundation will provide an overview of its history, project updates, as well as projected activities going forward. The meeting will take place on May 14, 2014 and take place at the Pew Charitable Trusts. For more details and attendance information, click here.

Reagan-Udall Foundation and Alzheimer’s Association announce launch of Alzheimer’s Disease Regulatory Science Fellowship

March 27, 2014: The Alzheimer’s Association and the Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA) are pleased to announce the launch of a new fellowship to allow an experienced physician, dedicated to treating and studying Alzheimer’s disease, the opportunity to work collaboratively with the U.S. FDA. [details]

Additional applicant information can be found here.

 

2013
 Reagan-Udall Foundation Announces Board Transitions and New Additions

November 21, 2013: For details see full announcement here.

IMEDS/OMOP Research Investigator, Dr. Marc Suchard, receives the 2013 Committee of Presidents of Statistical Societies (COPSS) Award by Joint Statistical Societies

August 15, 2013: Congratulations to OMOP Research Investigator, Dr. Marc Suchard who is the recipient of the 2013 Committee of Presidents of Statistical Societies (COPSS) Award by Joint Statistical Societies. [details]

Reagan-Udall Foundation for the FDA Appoints Steering Committee for Innovation in Medical Evidence Development and Surveillance Program 

June 11, 2013: The Reagan-Udall Foundation announces Innovation in Medical Evidence Development and Surveillance (IMEDS) Program Scientific Advisory Committee nomination and selection process. [details]

Reagan-Udall Foundation Seeks Nominations for IMEDS Scientific Advisory Committee

June 6, 2013: The Reagan-Udall Foundation announces Innovation in Medical Evidence Development and Surveillance (IMEDS) Program Scientific Advisory Committee nomination and selection process. [details]

Reagan-Udall Foundation Seeks Nominations for IMEDS Steering Committee

April 18, 2013: The Reagan-Udall Foundation announces Innovation in Medical Evidence Development and Surveillance (IMEDS) Program Steering Committee nomination and selection process. [details]

 

2012
 Reagan-Udall Foundation Receives FDA Funding to Advance Regulatory Science 

June 13, 2012: Press release announcing transfer from the FDA to support Reagan-Udall Foundation FY2012 operations and infrastructure [details